<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>16</Volume>
				<Issue>9</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>09</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>3867</FirstPage>
			<LastPage>3870</LastPage>
			<ELocationID EIdType="pii">30752</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;b&gt;Background:&lt;/b&gt; To explore whether combined detection of serum tumor markers (CEA, CA72-4, CA19-9 andTSGF) improve the sensitivity and accuracy in the diagnosis of gastric cancer (GC). Materials and &lt;br/&gt;&lt;b&gt;Methods&lt;/b&gt;: Anautomatic chemiluminescence immune analyzer with matched kits were used to determine the levels of serumCEA, CA72-4, CA19-9 and TSGF in 45 patients with gastric cancer (GC group), 40 patients with gastric benigndiseases (GBD group) hospitalized in the same period and 30 healthy people undergoing a physical examination.The values of those 4 tumor markers in the diagnosis of gastric cancer was analyzed. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: The levels ofserum CEA, CA72-4, CA19-9 and TSGF of the GC group were higher than those of the GBD group and healthyexamined people and the differences were significant (P&lt;0.001). The area under receiver operating characteristic(ROC) curves for single detection of CEA, CA72-4, CA19-9 and TSGF in the diagnosis of GC was 0.833, 0.805,0.810 and 0.839, respectively. The optimal cutoff values for these 4 indices were 2.36 ng/mL, 3.06 U/mL, 5.72 U/mL and 60.7 U/mL, respectively. With combined detection of tumor markers, the diagnostic power of those 4indices was best, with an area under the ROC curve of 0.913 (95%CI 0.866~0.985), a sensitivity of 88.9% anda diagnostic accuracy of 90.4%. &lt;br/&gt;&lt;b&gt;Conclusions&lt;/b&gt;: Combined detection of serum CEA, CA72-4, CA19-9 and TSGFincreases the sensitivity and accuracy in diagnosis of GC, so it can be regarded as the important means for earlydiagnosis.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Gastric cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Tumor marker</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">carbohydrate antigen 72-4</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">carcino-embryonic antigen</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_30752_a38465f64e4a5c3f11bdea16421b2294.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
